SLE patients produce type I interferon, which can shift initial CD4 T cells from Th1 subtype to the predominant Tfh cell phenotype, promoting B cell differentiation, immunoglobulin class switching, and ultimately leading to secretion of anti-nuclear antibodies (ANA) (65, 66). Here, CD4 is linked to systemic lupus erythematosus.